Carbon Health buys virtual diabetes clinic firm Steady Health
EMA starts review of Xtandi in hormone-sensitive prostate cancer
South Korean firm looking to develop novel drugs
Samsung Bioepis signs R&D agreement with Takeda
Drug could be filed after “outlier” analysis.
Growth hormone could be filed without further trials, says OPKO
OPKO weekly growth hormone jab fails in phase 3